Skip to Content

Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate Pregnancy and Breastfeeding Warnings

Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate is also known as: Hyophen, Methylphen, Prosed DS, Urophen MB

Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate Pregnancy Warnings

This drug combination has not been studied in animals or humans. It is unknown if it could cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk.

US FDA pregnancy category: C

Comments:
-Hyoscyamine and methenamine cross the placenta.

See references

Benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Yes (hyoscyamine, methenamine); Data not available (benzoic acid, methylene blue, phenyl salicylate)

Comments:
-The effects on the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Hyophen (benzoic acid/hyoscy/methen/mblue/phenylsal)." BioComp Pharma, San Antonio, TX.

References for breastfeeding information

  1. "Product Information. Hyophen (benzoic acid/hyoscy/methen/mblue/phenylsal)." BioComp Pharma, San Antonio, TX.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide